Palmitoylated pentapeptide lipidation chemistry

Lipidation changes the whole analytical profile

<a href="/product/cp-061">CP-061 Matrixyl</a> is cataloged as a Pal-pentapeptide-4 reference standard. The key structural event is palmitoylation: a C16 fatty acyl group attached to the peptide scaffold. That single lipid tail changes retention time, solubility, aggregation tendency, and impurity interpretation. For in-vitro research and cosmetic raw material formulation, Matrixyl should therefore be introduced as a lipidated peptide reference standard rather than as a simple five-residue peptide.

The prompt language mentions Matrixyl 3000, which often refers to a commercial blend context. The verified local catalog, however, lists CP-061 as Matrixyl / Pal-pentapeptide-4 and does not list a separate palmitoyl tetrapeptide-7 SKU. This article keeps the CP-061 link anchored to the verified catalog and flags the blend naming for human review in the manifest. That is the safer path: amplify existing PDP content without inventing a second component or SKU.

What palmitoylation does to a KTTKS scaffold

KTTKS is a lysine-threonine-threonine-lysine-serine pentapeptide derived from a type I procollagen sequence region. Palmitoylation adds a long hydrophobic chain, normally through an amide linkage, and turns the molecule into a peptide amphiphile. The peptide head carries polar and ionisable groups; the C16 tail drives hydrophobic interaction with reversed-phase media and formulation matrices. A Matrixyl COA should make that modification visible by mass and chromatographic behaviour.

Incomplete palmitoylation is the major structural impurity to look for. Unmodified KTTKS should elute earlier than the lipidated product on a C18 gradient because it lacks the hydrophobic tail. A well-designed release method separates the lipidated main peak from free pentapeptide, deletion products, and side-chain-protected remnants. HPLC-MS verified identity then confirms that the late-retained peak has the expected modified mass rather than merely showing a hydrophobic impurity.

Why C18 retention is the practical fingerprint

For non-lipidated cosmetic peptides such as <a href="/product/cp-060">CP-060 Argireline</a> and <a href="/product/cp-062">CP-062 SNAP-8</a>, residue composition and terminal caps dominate retention. For Pal-KTTKS, the palmitoyl chain becomes the main retention driver. A C18 method that resolves Argireline and SNAP-8 may need a different gradient window for Matrixyl because the C16 tail increases hydrophobic interaction and can broaden peak shape.

The best article angle is therefore methodological: explain how a lipidated reference standard reads on a COA. Readers need to know that a high HPLC area percent does not automatically prove palmitoylation yield unless the method resolves the free pentapeptide impurity. They also need to know that formulation solvents can change apparent recovery. The glossary entries for <a href="/glossary/lipidation">lipidation</a>, <a href="/glossary/palmitoylation">palmitoylation</a>, and <a href="/glossary/hplc">HPLC</a> should carry the reader through those terms.

Self-association and formulation buffers

Peptide amphiphiles can self-associate. That does not mean every Matrixyl sample forms a large aggregate under release conditions, but it does mean concentration, solvent composition, temperature, and ionic strength can change the species observed by the method. A procurement article should avoid promising one universal solubility behaviour. Instead, it should tell the reader to check the lot-specific compatibility note and to read the chromatographic method alongside the matrix used for sample preparation.

Canada Peptides can make this practical by presenting CP-061 beside the broader cosmetic set. <a href="/research-guide/acetyl-capped-cosmetic-peptides">Argireline and SNAP-8 acetyl-capped sequence design</a> covers oxidation and terminal caps. <a href="/research-guide/ghk-cu-copper-peptide-complexes">GHK-Cu copper peptide complex chemistry</a> covers coordination stoichiometry. CP-061 adds lipidation and amphiphile behaviour. Together, the three articles show that cosmetic peptide quality is not one method repeated across all molecules.

What the CP-061 COA should show

A tight CP-061 release file should include the expected molecular weight, HPLC-MS verified identity of the palmitoylated species, reversed-phase purity, a note on unmodified KTTKS if detected, Karl Fischer water content, and residual solvent data. The product page can stay concise, but the article should teach the reviewer what each line protects against. Molecular weight protects against wrong scaffold. Retention and mass together protect against incomplete acylation. Water and solvent lines protect the mass accounting of the vial.

The article should also explain why the bare pentapeptide and the palmitoylated species should not be treated as interchangeable reference materials. They have different polarity, different chromatographic behaviour, and different formulation relevance. That distinction is structural, not promotional. It keeps the page inside the RUO frame and makes the content useful to postdocs, procurement officers, and cosmetic-formulation teams.

Internal linking and patch logic

The ADD entry in the reverse-index patch should attach this article to CP-061. Adjacent UPDATE entries can attach it to CP-060, CP-062, and CP-035 if the production team wants the cosmetic cluster to cross-promote. Inline product links should use lower-case PDP routes: <a href="/product/cp-061">Matrixyl</a>, <a href="/product/cp-060">Argireline</a>, <a href="/product/cp-062">SNAP-8</a>, and <a href="/product/cp-035">GHK-Cu</a>.

The article should remain for in-vitro research use only and not for human or veterinary use and should avoid finished-product claims. It is a chemistry page about a research reference standard from Canada Peptides in Toronto: how the C16 chain changes the analytical evidence and how a buyer should read that evidence before accepting the lot into an in-vitro programme.

Summary

Palmitoylation turns a short peptide into an amphiphilic reference standard. The C16 chain shifts HPLC retention, changes solvent behaviour, and creates a specific impurity question: was the palmitoyl group installed and verified on the dominant species? CP-061 should therefore be linked to a lipidation article rather than only to a generic cosmetic peptide page.

Because the verified catalog does not list a separate palmitoyl tetrapeptide-7 SKU, the production copy should avoid claiming a Matrixyl 3000 blend unless the catalog or COA is updated. The article can still rank for palmitoylated pentapeptide chemistry while staying faithful to the local data.

Release-file review checklist

For release-file review, keep the chemistry anchored to the verified SKU list: CP-061, CP-060, CP-062, CP-035. Confirm sequence or scaffold, molecular weight, HPLC-MS verified identity, counter-ion or modification state, water content, and residual-solvent method before copying the article into a production CMS. Canada Peptides should keep each inline product reference tied to the lower-case PDP route and should keep the article language limited to research reference standard selection, analytical characterisation, and procurement traceability. If a future catalog update changes a molecular weight, adds a salt form, or introduces a new related product, revise the cross-links and the patch file before publication rather than editing the claim in isolation.

Human review should decide whether production wants to add a separate palmitoyl tetrapeptide-7 product later. This package does not create or imply an unverified SKU.

Procurement traceability notes

A procurement reader should be able to move from this article to a PDP, from the PDP to a lot COA, and from the COA to a reproducible method record without guessing. That means names, SKU codes, molecular weights, and analytical terms must stay consistent across the article body, glossary, and reverse-index patch. The article should therefore be handled as a controlled content asset: update the reviewed date, check the DOI links, rerun the banned-phrase scan, and confirm the article still links to at least three product pages and two research-guide resources before publication.

Publication integration notes

The Matrixyl article should be positioned as the lipidation page for the cosmetic cluster. It has a different search role from the acetyl-capped peptide article: the main query pattern is Pal-KTTKS, palmitoylated pentapeptide, lipidated peptide, and C16 retention behaviour. The article therefore needs the CP-061 PDP link early, the palmitoylation glossary link near the method discussion, and at least one cross-link back to Argireline and SNAP-8 so the reader understands that terminal caps and lipid tails are separate modification classes.

The highest-risk implementation issue is the Matrixyl 3000 wording from the prompt. Because the verified catalog only supports CP-061 Matrixyl / Pal-pentapeptide-4, this article should not describe a two-component blend as if it were the local product. If Jay adds a palmitoyl tetrapeptide-7 SKU later, the article can be expanded and the reverse-index patch can gain another ADD entry. Until then, the clean answer is to rank for the lipidation chemistry while documenting the catalog gap in the manifest.

CMS acceptance notes

Before this object is pasted into the production article array, verify that the slug is unique, the title stays under the search-result length target, the meta description remains in the 150-160 character band, and each internal link resolves to an existing route. Keep the relatedSKUs array uppercase because the article object is a data artifact, while inline PDP links should stay lower-case to match the current route style. This separation prevents a reader-facing URL change from corrupting the SKU key used by the reverse index.

The publication checklist should be mechanical. Parse the JS file, count body words before the references section, scan the body for blocked phrases, confirm at least five DOI-backed citations, count FAQ objects, count H2 headings, and count PDP and research-guide links. Then compare the article's SKU list with pdp_to_article_map_v3_patch.json. If the content and patch disagree, fix both in the same edit. That discipline matters more than adding another paragraph because these articles exist to repair internal linking while preserving catalog truth.

References

1. Katayama, K., Armendariz-Borunda, J., Raghow, R., Kang, A. H., & Seyer, J. M. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry, 268(14), 9941–9944. DOI: 10.1016/s0021-9258(18)82153-682153-6) 2. Choi, Y. L., Park, E. J., Kim, E., Na, D. H., & Shin, Y.-H. (2014). Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS). Biomolecules &Amp; Therapeutics, 22(4), 321–327. DOI: 10.4062/biomolther.2014.053 3. Lintner, & Peschard. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International Journal of Cosmetic Science, 22(3), 207–218. DOI: 10.1046/j.1467-2494.2000.00010.x 4. Palladino, P., Castelletto, V., Dehsorkhi, A., Stetsenko, D., & Hamley, I. W. (2012). Conformation and Self-Association of Peptide Amphiphiles Based on the KTTKS Collagen Sequence. Langmuir, 28(33), 12209–12215. DOI: 10.1021/la302123h 5. Jones, R. R., Castelletto, V., Connon, C. J., & Hamley, I. W. (2013). Collagen Stimulating Effect of Peptide Amphiphile C16–KTTKS on Human Fibroblasts. Molecular Pharmaceutics, 10(3), 1063–1069. DOI: 10.1021/mp300549d

Frequently asked questions

References

1. Katayama, K., Armendariz-Borunda, J., Raghow, R., Kang, A. H., & Seyer, J. M. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry, 268(14), 9941–9944. · link
2. Choi, Y. L., Park, E. J., Kim, E., Na, D. H., & Shin, Y.-H. (2014). Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS). Biomolecules &Amp; Therapeutics, 22(4), 321–327. · link
3. Lintner, & Peschard. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International Journal of Cosmetic Science, 22(3), 207–218. · link
4. Palladino, P., Castelletto, V., Dehsorkhi, A., Stetsenko, D., & Hamley, I. W. (2012). Conformation and Self-Association of Peptide Amphiphiles Based on the KTTKS Collagen Sequence. Langmuir, 28(33), 12209–12215. · link
5. Jones, R. R., Castelletto, V., Connon, C. J., & Hamley, I. W. (2013). Collagen Stimulating Effect of Peptide Amphiphile C16–KTTKS on Human Fibroblasts. Molecular Pharmaceutics, 10(3), 1063–1069. · link

References

1. Unknown author (2005). Use of a facial moisturizer containing palmitoyl pentapeptide improves the appearance of aging skin. Journal of the American Academy of Dermatology. · DOI
2. Katayama K., Armendariz-Borunda J., Raghow R. et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry. · DOI
3. Blanes‐Mira C., Clemente J., Jodas G. et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science. · DOI
4. Merrifield R. (1963). Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. · DOI
5. FIELDS G., NOBLE R. (1990). Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids. International Journal of Peptide and Protein Research. · DOI
6. Aguilar M. (n.d.). HPLC of Peptides and Proteins: Basic Theory and Methodology. HPLC of Peptides and Proteins. · DOI
7. Whitelegge J. (n.d.). HPLC and Mass Spectrometry of Intrinsic Membrane Proteins. HPLC of Peptides and Proteins. · DOI
8. Rauh M. (2012). LC–MS/MS for protein and peptide quantification in clinical chemistry. Journal of Chromatography B. · DOI